2013
DOI: 10.1007/s00296-013-2852-7
|View full text |Cite
|
Sign up to set email alerts
|

Negative affect in systemic sclerosis

Abstract: Negative affect appears frequently in rheumatic diseases, but studies about their importance and prevalence in systemic sclerosis patients are scarce, and the results are inconclusive separately. We conducted a comprehensive search on April 2013 of PubMed, Medline, and PsycINFO databases to identify original research studies published. A total of 48 studies were included in this systematic review. We found negative emotions have very high levels in these patients, compared to both healthy population other chro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 57 publications
0
13
0
Order By: Relevance
“…Another reason might be that several patients categorized in the N group presented with subnormal exercise capacity due to deconditioning. Chronic inflammation, pain, musculoskeletal disuse due to cutaneous lesions or arthritis, chronic anxiety and depression, social withdrawal or isolation due to disfigurement and potential adverse effects of corticosteroid use on emotional status and muscular function [25,26,27] are only some of the potential factors leading to decreased physical activity and increased exertional dyspnea among these patients, without evident heart or lung involvement being present.…”
Section: Discussionmentioning
confidence: 99%
“…Another reason might be that several patients categorized in the N group presented with subnormal exercise capacity due to deconditioning. Chronic inflammation, pain, musculoskeletal disuse due to cutaneous lesions or arthritis, chronic anxiety and depression, social withdrawal or isolation due to disfigurement and potential adverse effects of corticosteroid use on emotional status and muscular function [25,26,27] are only some of the potential factors leading to decreased physical activity and increased exertional dyspnea among these patients, without evident heart or lung involvement being present.…”
Section: Discussionmentioning
confidence: 99%
“…Depression is more common in SSc patients than in patients with other rheumatic diseases [ 4 , 5 ]. Symptoms of depression occur in approximately one-third to two-thirds of patients with SSc [ 6 ], depending on which questionnaire is used and whether or not the prevalence of depression is based on valid interview methods [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Symptoms of depression occur in approximately one-third to two-thirds of patients with SSc [ 6 ], depending on which questionnaire is used and whether or not the prevalence of depression is based on valid interview methods [ 7 ]. Disease-specific symptoms such as reflux, constipation, dyspnea, digital ulcers, pain, fatigue, and changes in physical appearance are associated with negative emotions in SSc [ 4 ]. Depressive symptoms are associated with poor HRQL [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Emotional suppression was found to be a dysfunctional emotion regulation strategy, while cognitive reappraisal was found to be adaptive ( Werner and Gross, 2010 ). Although research has demonstrated a possible temporal association between psychological distress and onset, recurrence, and severity of psoriasis ( Stewart et al, 2018 ), as well as the presence of high levels on negative affect in SSc patients ( Leon et al, 2014 ), few studies have examined whether expressive suppression or cognitive reappraisal predicted well-being or psychological distress in dermatological patients. For example, Chung et al (2018) have found that the suppression of depression predicted psychiatric co-morbidity in patients with chronic idiopathic urticaria, suggesting the important role of expressive suppression in skin diseases.…”
Section: Introductionmentioning
confidence: 99%